🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project

RecruitingNAAges 18 Years - anyAllUniversity of Sao Paulo General Hospital
NCT06786819 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cardiovascular diseases continue to be the leading cause of death worldwide. Among them, coronary artery disease has the greatest impact, being characterized as one of the main causes of death in Brazil over the last decade. One of the well-established treatments is coronary artery bypass grafting, which is the most performed among cardiac surgeries and, in our scenario, is primarily funded by the Unified Health System (SUS). The information obtained from the Paulista Registry of Cardiovascular Surgeries (REPLICCAR), in partnership with FAPESP, has been important for implementing improvements in the landscape of cardiac surgeries in the state of São Paulo. Although outcomes in cardiac surgery have improved due to the structuring and organization of quality programs, this is still not a reality at the national level. In a situation where data collection and quality initiatives play a cent

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults over 18 years old * Indication for primary isolated CABG (elective or urgent status) * Own a personal cell phone * Have internet access * Knowledgeable in using the device * Full understanding and agreement regarding the informed consent form (ICF) Exclusion Criteria: * Indication for associated surgery * Glycosylated hemoglobin level greater than 8% * Creatinine clearance less than 30 mL/min * Pre-operative atrial fibrillation or use of pre-operative anticoagulation * Hemoglobin less than 12 g/dL * Users of illicit drugs * STS score greater than 4% * Physical or mental disabilities that prevent adherence to the protocol * Refusal by the patient or family member
💊

What it tests

  • ERACS with Digital Platform
📍

Where

2 sites
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, Brazil
InCor - Instituto do Coração do Hospital das Clínicas da FMUSP
São Paulo, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy